At a glance
- Originator Eli Lilly and Company
- Class Antithrombotics; Indoles; Piperidines; Small molecules
- Mechanism of Action Thrombin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Thrombosis
Most Recent Events
- 22 Feb 1999 New profile
- 22 Feb 1999 Preclinical development for Thrombosis in USA (Unknown route)